MF

Maurizio Fazio

Principal at Atlas Venture

Cambridge, Massachusetts

Overview 

Maurizio Fazio is a Principal at Atlas Venture in Cambridge, Massachusetts, with a background in oncology, cancer research, and stem cells. He has a Doctor of Philosophy from Harvard University and a Doctor of Medicine from Libera Università Vita-Salute San Raffaele, and has held roles at prestigious institutions like Boston Children's Hospital and Memorial Sloan-Kettering Cancer Center. Fazio's career highlights include serving as a Board Observer for companies like AAVantgarde Bio and Accent Therapeutics, Inc., and being involved in education and innovation at Harvard University as an Education Innovation Fellow.

Work Experience 

AV

Atlas Venture

  • Principal

    2024 - Current

  • Senior Associate

    2023 - 2023

  • Associate

    2021 - 2022

Atlas Venture creates and invests in biotech startup companies with seed and early stage venture investments.

atlasventure.com
AB

AAVantgarde Bio

  • Board Observer

    2023

AT

Accent Therapeutics, Inc.

  • Board Observer

    2022

Accent Therapeutics is a biopharmaceutical company.

Raised $178,000,000.00 from Bristol-Myers Squibb, Atlas Venture, NS Investment, Mirae Asset Venture Investment, EcoR1 Capital, Mirae Asset Capital, The Mark Foundation for Cancer Research, Droia Ventures, The Column Group and Mirae Asset Capital Life Science.

accenttx.com
VB

Vedere Bio II

  • Board Observer

    2021 - 2023

Vedere Bio is developing gene therapy products to restore functional vision to patients who have suffered vision loss.

Raised $98,000,000.00 from Octagon Capital Advisors, Retinal Degeneration Fund, Casdin Capital, Atlas Venture, Samsara BioCapital, Mission BioCapital, Foundation Fighting Blindness, Atlas Venture and Mission BioCapital.

vederebio.com
BC

Boston Children's Hospital

  • PhD Candidate

    2015 - 2021

    In Leonard Zon`s lab, I used zebrafish, mouse, and in vitro human melanoma disease models to identify genetic and epigenetic drivers sculpting cancer evolution towards metastasis and drug resistance

Briarpatch Pediatrics is a pediatric center that provides health care services to children.

childrenshospital.org
FP

Flagship Pioneering

  • Fellow

    2020 - 2020

Flagship Pioneering is a venture capital firm that invests in life sciences and healthcare companies.

flagshippioneering.com
VV

Vida Ventures, LLC

  • Fellow

    2019 - 2020

Vida Ventures is a next-generation life sciences investment firm .

vidaventures.com
HU

Harvard University

  • Education Innovation Fellow - HILT Operation Impact

    2019 - 2020

  • Instructor

    2017 - 2019

    Designed and taught two courses at the Harvard Summer School, Pre-College program: - BIOS P-13515 The Promises of Regenerative Medicine - BIOS P-13510 Why Haven't We Cured Cancer Yet? Insights from Evolution, Ecology, and Paleontology

  • Teaching Fellow

    2015 - 2019

MS

Memorial Sloan-Kettering Cancer Center

  • Research Fellow

    2013 - 2014

    Human Oncology and Pathogenesis Program - Armstrong lab Target discovery in high-risk pediatric leukemia

UV

Università Vita-Salute San Raffaele Milano

  • Medical student - Functional Genomics of Cancer Unit, Division of Molecular Oncology - Tonon's Lab

    2011 - 2012

  • Medical student - Cancer Gene and Immunotherapy program - Bonini`s Lab

    2011 - 2011

Education 

Articles About Maurizio

Relevant Websites